They also found that the expression level of Bcl2 was considerably reduced in the tumor after treatment of the Ehrlich solid tumor-bearing mice with 10-HDA at doses of 2.5 and 5 mg/kg, especially in combination with cyclophosphamide [19]. The gene discussed is BCL2; the disease is neoplasm.